Tumor lactic acidosis suppresses CTL function by inhibition of p38 and JNK/c‐Jun activation

Lactic acidosis is common to most solid tumors and has been found to affect infiltrating immune cells. Here we document effector phase inhibition of cytotoxic T cells (CTLs) involving complete blockage of cytokine production and partial impairment of lytic granule exocytosis. Lactic acidosis impaired TCR‐triggered phosphorylation of JNK, c‐Jun and p38, while not affecting MEK1 and ERK. The select targeting of signaling proteins involved in IFNγ production (JNK/c‐Jun, p38) without affecting those jointly used in cytokine regulation and granule exocytosis (MEK1/ERK) explains the observed split effect of lactic acidosis on the CTL responses. CTL inhibition by lactic acidosis showed fast dynamics with immediate onset and reversion. Functional recovery by neutralizing the extracellular pH despite continuous presence of lactate holds promise that CTL activity can be improved in the milieu of solid tumors with appropriate anti‐acidosis treatment, thereby increasing the efficacy of adoptive T cell therapy.

[1]  O. Warburg [On the facultative anaerobiosis of cancer cells and its use in chemotherapy]. , 1961, Munchener medizinische Wochenschrift.

[2]  G. Riethmüller,et al.  Tumor-specific lysis of human renal cell carcinomas by tumor-infiltrating lymphocytes. I. HLA-A2-restricted recognition of autologous and allogeneic tumor lines. , 1993, Journal of immunology.

[3]  Christoph W. Turck,et al.  Nuclear Export of NF-ATc Enhanced by Glycogen Synthase Kinase-3 , 1997, Science.

[4]  N. Price,et al.  The proton-linked monocarboxylate transporter (MCT) family: structure, function and regulation. , 1999, The Biochemical journal.

[5]  E. Rofstad,et al.  High lactate levels predict likelihood of metastases, tumor recurrence, and restricted patient survival in human cervical cancers. , 2000, Cancer research.

[6]  H. Pircher,et al.  Lack of Effector Cell Function and Altered Tetramer Binding of Tumor-Infiltrating Lymphocytes , 2002, The Journal of Immunology.

[7]  R. Gillies,et al.  Why do cancers have high aerobic glycolysis? , 2004, Nature Reviews Cancer.

[8]  C. Perreault,et al.  T cells targeted against a single minor histocompatibility antigen can cure solid tumors , 2005, Nature Medicine.

[9]  J. Viola,et al.  IFN-γ Production by CD8+ T Cells Depends on NFAT1 Transcription Factor and Regulates Th Differentiation1 , 2005, The Journal of Immunology.

[10]  Weiping Zou,et al.  Immunosuppressive networks in the tumour environment and their therapeutic relevance , 2005, Nature Reviews Cancer.

[11]  C. Blank,et al.  Immune resistance orchestrated by the tumor microenvironment , 2006, Immunological reviews.

[12]  A. Frey,et al.  T-cell receptor signaling events triggering granule exocytosis. , 2006, Critical reviews in immunology.

[13]  A. Frey,et al.  Effector‐phase tolerance: another mechanism of how cancer escapes antitumor immune response , 2006, Journal of leukocyte biology.

[14]  IFN-γ Regulates Donor CD8 T Cell Expansion, Migration, and Leads to Apoptosis of Cells of a Solid Tumor1 , 2006, The Journal of Immunology.

[15]  E. Noessner,et al.  Immune suppression in renal cell carcinoma. , 2007, Seminars in cancer biology.

[16]  E. Rieber,et al.  Adoptive transfer of cytotoxic T-cells for treatment of residual disease after irradiation , 2007, International journal of radiation biology.

[17]  Gregor Rothe,et al.  Inhibitory effect of tumor cell-derived lactic acid on human T cells. , 2007, Blood.

[18]  R. Vaughan-Jones,et al.  Extracellular Acidification Elicits Spatially and Temporally Distinct Ca2+ Signals , 2008, Current Biology.

[19]  D. Morgan,et al.  Loss of CTL function among high-avidity tumor-specific CD8+ T cells following tumor infiltration. , 2008, Cancer research.

[20]  A. Mackensen,et al.  Tumor-induced modulation of dendritic cell function. , 2008, Cytokine & growth factor reviews.

[21]  M. West,et al.  The Genomic Analysis of Lactic Acidosis and Acidosis Response in Human Cancers , 2008, PLoS genetics.

[22]  S. Rosenberg,et al.  Adoptive cell therapy for the treatment of patients with metastatic melanoma. , 2009, Current opinion in immunology.

[23]  Robert J Gillies,et al.  The potential role of systemic buffers in reducing intratumoral extracellular pH and acid-mediated invasion. , 2009, Cancer research.

[24]  H. Ikeda,et al.  Tumor progression inhibits the induction of multifunctionality in adoptively transferred tumor‐specific CD8+ T cells , 2009, European journal of immunology.

[25]  Roger J. Davis,et al.  Regulation of the immune response by stress‐activated protein kinases , 2009, Immunological reviews.

[26]  Bonnie F. Sloane,et al.  Bicarbonate increases tumor pH and inhibits spontaneous metastases. , 2009, Cancer research.

[27]  Morgan Huse,et al.  The T-cell-receptor signaling network , 2009, Journal of Cell Science.

[28]  T. Blankenstein,et al.  T-Cell Receptor Gene–Modified T Cells with Shared Renal Cell Carcinoma Specificity for Adoptive T-Cell Therapy , 2010, Clinical Cancer Research.

[29]  A. Fischer,et al.  Molecular mechanisms of biogenesis and exocytosis of cytotoxic granules , 2010, Nature Reviews Immunology.